NYLIM
LUNG icon

New York Life Investment Management’s Pulmonx LUNG Stock Holding History

New York Life Investment Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-31,129
Closed -$397K – 1444
2023
Q4 		$397K Sell
31,129
-717
-2% -$7.47K ﹤0.01% 1004
2023
Q3 		$329K Sell
31,846
-5,018
-14% -$58.1K ﹤0.01% 1064
2023
Q2 		$483K Sell
36,864
-6,358
-15% -$77.8K 0.01% 746
2023
Q1 		$483K Buy
+43,222
New +$427K 0.01% 838

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

New York Life Investment Management's LUNG Position: Q1 2024 in Review

New York Life Investment Management sold out of Pulmonx (LUNG) in Q1 2024, closing a stake of 31,129 shares — an estimated $397K sold.

New York Life Investment Management first reported a position in LUNG in Q1 2023 and held it in 4 quarters. The position peaked at $483K in Q2 2023. 118 funds tracked by Wall St. Rank hold LUNG as of Q1 2024.

  • New York Life Investment Management reported no remaining Pulmonx position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 31,129 Pulmonx shares in Q1 2024, an estimated $397K.
  • New York Life Investment Management first reported a position in Pulmonx in Q1 2023 and held it in 4 quarters.
  • New York Life Investment Management's Pulmonx position peaked at $483K in Q2 2023.
  • 118 funds tracked by Wall St. Rank held Pulmonx as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.